Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immix Biopharma, Inc. - Common Stock
(NQ:
IMMX
)
1.970
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immix Biopharma, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 12, 2022
Gainers Immuron (NASDAQ:IMRN) shares rose 36.6% to $3.58 during Wednesday's regular session. Trading volume for this security as of 12:32 EST is 35.0 million, which is...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 2%; Philips Shares Plummet
January 12, 2022
Midway through trading Wednesday, the Dow traded up 0.26% to 36,346.85 while the NASDAQ rose 0.77% to 15,270.07. The S&P also rose, gaining, 0.57% to 4,739.98. The U.S. has...
Via
Benzinga
28 Stocks Moving In Wednesday's Mid-Day Session
January 12, 2022
Gainers Immuron Limited (NASDAQ: IMRN) shares jumped 40.2% to $3.5887. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing...
Via
Benzinga
Immix's Lead Program Shows 50% Response Rate In Resistant Cancer In Animal Study
January 12, 2022
Immix Biopharma Inc (NASDAQ: IMMX) announced preclinical data of its lead program, IMX-110. The data showed that IMX-110 produced a 50% response rate in first-line...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 12, 2022
Gainers Immuron (NASDAQ:IMRN) stock moved upwards by 69.5% to $4.44 during Wednesday's pre-market session. The market value of their outstanding shares is at $25.2...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 11, 2022
Gainers Nutriband (NASDAQ:NTRB) stock moved upwards by 20.7% to $7.29 during Tuesday's regular session. Trading volume for Nutriband's stock is 6.4 million as of...
Via
Benzinga
45 Stocks Moving In Monday's Mid-Day Session
January 10, 2022
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88. Zynga Inc. (NASDAQ: ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired...
Via
Benzinga
60 Biggest Movers From Yesterday
January 11, 2022
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company...
Via
Benzinga
The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming
January 10, 2022
Biotech stocks came under selling pressure along with the broader market, as rate hike fears seized Wall Street. The news flow, however, was scanty. Last week, the Food and Drug...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 07, 2022
Gainers Absci (NASDAQ:ABSI) shares increased by 51.5% to $9.3 during Friday's pre-market session. The market value of their outstanding shares is at $861.1 million....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 07, 2022
It's the final day of trading this week and we're starting it off with an overview of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
21 Stocks Moving in Friday's Pre-Market Session
January 07, 2022
Gainers Absci Corporation (NASDAQ: ABSI) rose 40.9% to $8.65 in pre-market trading after the company reported a research collaboration with Merck. Marin Software Incorporated (...
Via
Benzinga
58 Biggest Movers From Yesterday
January 07, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...
Via
Benzinga
45 Biggest Movers From Yesterday
January 05, 2022
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
January 04, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...
Via
Benzinga
Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Drops To 58.7
January 04, 2022
Following the market opening Tuesday, the Dow traded up 0.74% to 36,857.55 while the NASDAQ fell 0.14% to 15,811.30. The S&P also rose, gaining 0.40% to 4,815.75. The U.S. has...
Via
Benzinga
Why Immix Biopharma Shares Are Rising Today
January 04, 2022
Immix Biopharma Inc (NASDAQ: IMMX) is trading higher Tuesday on continued momentum after the U.S. Food and Drug Administration granted Rare Pediatric Disease...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 04, 2022
Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 68.7% to $1.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $28....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 04, 2022
Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
23 Stocks Moving in Tuesday's Pre-Market Session
January 04, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc...
Via
Benzinga
EXCLUSIVE: Immix CEO On FDA Designation, Positioning, Price Action On 'Benzinga Live'
January 03, 2022
Immix Biopharma Inc (NASDAQ: IMMX) stock is soaring Monday after the U.S. Food and Drug Administration granted Rare Pediatric Disease designation for IMX-110 for the...
Via
Benzinga
Mid-Afternoon Market Update: Dow Surges 150 Points; Applied Therapeutics Shares Slide
January 03, 2022
Toward the end of trading Monday, the Dow traded up 0.43% to 36,496.18 while the NASDAQ rose 0.93% to 15,790.97. The S&P also rose, gaining 0.43% to 4,786.68. The U.S. has the...
Via
Benzinga
61 Biggest Movers From Yesterday
January 04, 2022
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 03, 2022
Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million...
Via
Benzinga
Dow Flat as Tesla Lifts Tech, Autos
January 03, 2022
The Dow Jones Industrial Average is flat midday, as it cools off from this morning's burst higher. Both the S&P 500 Index and Nasdaq Composite are more comfortably in the black.
Via
Talk Markets
Mid-Day Market Update: Gold Down 1%; Immix Biopharma Shares Spike Higher
January 03, 2022
Midway through trading Monday, the Dow traded up 0.18% to 36,402.21 while the NASDAQ rose 0.75% to 15,762.21. The S&P also rose, gaining 0.23% to 4,776.99. The U.S. has the...
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
January 03, 2022
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-...
Via
Benzinga
8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE
January 03, 2022
We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading.
Via
InvestorPlace
BLCT Stock: 7 Things to Know About LGBT Platform BlueCity Holdings and the Spriver Tech Deal
January 03, 2022
BlueCity Holdings (BLCT) has announced an offer for the company's stock from Baoli Ma and Spriver Tech Limited and we've got the details.
Via
InvestorPlace
IMMX Stock Alert: The Massive FDA Win That Has Immix Biopharma Blasting Higher Today
January 03, 2022
Immix Biopharma (IMMX) stock is taking off Monday thanks to a Rare Pediatric Disease designation from the U.S. Food and Drug Administration.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.